Alnylam Pharmaceuticals
ALNY
#641
Rank
โ‚น2.750 T
Marketcap
โ‚น21,246
Share price
-1.30%
Change (1 day)
70.92%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company